RS-40 is a THC-dominant dried cannabis flower presented in a 5g unit, manufactured under full GMP conditions by ECS Botanics in Australia. The flower is cultivated by licensed global partners operating under validated quality systems and is processed at ECS’s GMP-certified Australian facility. Pharmaceutical-grade post-harvest procedures are applied, including microbial and stability testing, QA batch release, and packaging in tamper-evident, child-resistant containers. 

This chemovar was developed by Deep East through a targeted breeding program involving Pink Guava and OZK lineage from TerpHogz Genetics. It has been stabilised through multiple selection cycles to support chemotypic consistency and terpene retention. The current batch expresses ~24.5% w/w total cannabinoids, predominantly as Δ9-THC. 

The terpene profile is batch-specific but commonly includes limonene, beta-caryophyllene, and linalool. No therapeutic claims are made regarding individual constituents. 

Intended exclusively for vaporised administration. Prescribers should assess clinical suitability on a patient-specific basis. 

RS-40 is available under the Special Access Scheme Category B or Authorised Prescriber pathways in accordance with TGO 93. Batch-specific Certificates of Analysis confirming cannabinoid concentration, and microbial compliance are available upon request.